5JF2
| Crystal structure of type 2 PDF from Streptococcus agalactiae in complex with inhibitor AT002 | Descriptor: | (3R)-3-{3-[(4-fluorophenyl)methyl]-1,2,4-oxadiazol-5-yl}-N-hydroxyheptanamide, ACETATE ION, IMIDAZOLE, ... | Authors: | Fieulaine, S, Giglione, C, Meinnel, T, Hamiche, K. | Deposit date: | 2016-04-19 | Release date: | 2016-11-30 | Last modified: | 2024-01-10 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | A unique peptide deformylase platform to rationally design and challenge novel active compounds. Sci Rep, 6, 2016
|
|
5JF7
| Crystal structure of type 2 PDF from Streptococcus agalactiae in complex with inhibitor SMP289 | Descriptor: | 2-(3-benzyl-5-bromo-1H-indol-1-yl)-N-hydroxyacetamide, ACETATE ION, IMIDAZOLE, ... | Authors: | Fieulaine, S, Giglione, C, Meinnel, T, Hamiche, K. | Deposit date: | 2016-04-19 | Release date: | 2016-11-30 | Last modified: | 2024-01-10 | Method: | X-RAY DIFFRACTION (2.1 Å) | Cite: | A unique peptide deformylase platform to rationally design and challenge novel active compounds. Sci Rep, 6, 2016
|
|
5JF6
| Crystal structure of type 2 PDF from Streptococcus agalactiae in complex with inhibitor 6b (AB47) | Descriptor: | 2-(5-bromo-1H-indol-3-yl)-N-hydroxyacetamide, ACETATE ION, Peptide deformylase, ... | Authors: | Fieulaine, S, Giglione, C, Meinnel, T, Hamiche, K. | Deposit date: | 2016-04-19 | Release date: | 2016-11-30 | Last modified: | 2024-01-10 | Method: | X-RAY DIFFRACTION (1.7 Å) | Cite: | A unique peptide deformylase platform to rationally design and challenge novel active compounds. Sci Rep, 6, 2016
|
|